Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Castells

Showing results (161-170 of 353) with videos related to

Pageof 36
Sort By:
Annals of Surgery|May 28, 2016
MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent CohortsElena Vila-Navarro, Maria Vila-Casadesús, Leticia Moreira, et al.
Gastrointestinal Endoscopy|August 2, 2011
EUS and magnetic resonance imaging in the staging of rectal cancer: a prospective and comparative studyGlòria Fernández-Esparrach, Juan R Ayuso-Colella, Oriol Sendino, et al.
Plos One|November 22, 2023
Clinical performance study of a fecal bacterial signature test for colorectal cancer screeningMarta Malagón, Elizabeth Alwers, Lia Oliver, et al.
Elife|January 16, 2020
CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implicationsSebastià Franch-Expósito, Laia Bassaganyas, Maria Vila-Casadesús, et al.
Clinical Epigenetics|October 4, 2023
Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomasMaría Gallardo-Gómez, Mar Rodríguez-Girondo, Núria Planell, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 2, 2020
Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal CancerSaray Duran-Sanchon, Lorena Moreno, Javier Gómez-Matas, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 28, 2022
Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study)Joaquín Sáez-Peñataro, Ferran Torres, Joan Bartra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2018
<i>TFAP2E</i> Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal CancerOscar Murcia, Rodrigo Jover, Cecilia Egoavil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathwayXavier Llor, Elisenda Pons, Rosa M Xicola, et al.
The Journal of Pathology|January 23, 2022
Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage II colon cancerSara Lahoz, Ivan Archilla, Elena Asensio, et al.
Pageof 36

Showing results (161-170 of 353) with videos related to

Sort By:
Pageof 36
Annals of Surgery|May 28, 2016
MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent CohortsElena Vila-Navarro, Maria Vila-Casadesús, Leticia Moreira, et al.
Gastrointestinal Endoscopy|August 2, 2011
EUS and magnetic resonance imaging in the staging of rectal cancer: a prospective and comparative studyGlòria Fernández-Esparrach, Juan R Ayuso-Colella, Oriol Sendino, et al.
Plos One|November 22, 2023
Clinical performance study of a fecal bacterial signature test for colorectal cancer screeningMarta Malagón, Elizabeth Alwers, Lia Oliver, et al.
Elife|January 16, 2020
CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implicationsSebastià Franch-Expósito, Laia Bassaganyas, Maria Vila-Casadesús, et al.
Clinical Epigenetics|October 4, 2023
Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomasMaría Gallardo-Gómez, Mar Rodríguez-Girondo, Núria Planell, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 2, 2020
Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal CancerSaray Duran-Sanchon, Lorena Moreno, Javier Gómez-Matas, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 28, 2022
Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study)Joaquín Sáez-Peñataro, Ferran Torres, Joan Bartra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2018
<i>TFAP2E</i> Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal CancerOscar Murcia, Rodrigo Jover, Cecilia Egoavil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathwayXavier Llor, Elisenda Pons, Rosa M Xicola, et al.
The Journal of Pathology|January 23, 2022
Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage II colon cancerSara Lahoz, Ivan Archilla, Elena Asensio, et al.
Pageof 36